An Interactive Preventive Health Record to Increase Colorectal Cancer Screening



Status:Enrolling by invitation
Conditions:Colorectal Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:50 - 75
Updated:2/6/2019
Start Date:August 2013
End Date:December 2019

Use our guide to learn which trials are right for you!

This study involves 3 phases that modifies current Interactive Preventative Health
Record-Colorectal Cancer Screening (IPHR-CRCS) modules to address each patient's individual
colorectal cancer screening (CRCS) knowledge, attitudes, preferences, and test-specific
barriers. The study will engage patients, ages 50-75 years who are non-adherent to CRCS, to
assess their CRCS test preferences and corresponding test-specific barriers in "real time".
Based on patient characteristics (e.g. age, personal and family history, physician CRCS
recommendation, CRCS test preferences, top test-specific barriers), tailored messages/videos
will appear in the pop-up screens to address/reduce the top patient-reported, test-specific
CRCS barriers while incorporating an action plan for CRCS adherence. The investigators
hypothesize that modifying the IPHR-CRCS module to address each patient's individual CRCS
knowledge, attitudes, preferences, and test-specific barriers will further increase CRCS.


Inclusion Criteria:

- Adults 50-75 years

- Non-adherent to CRCS guidelines (i.e., no FOBT in last year, no sigmoidoscopy or
barium enema in last 5 years, and no colonoscopy in last 10 years)

- English-speaking

- Have computer access (e.g. home, work, library)

- Additional eligibility for Phase I: focus group participants will be ineligible for
the subsequent prototype testing and cognitive/usability testing interviews

- Additional eligibility for Phase I: prototype testing participants will be ineligible
for the cognitive/usability testing interviews

- Additional eligibility for Phase II: Seen in the clinic in the last 2 years

Exclusion Criteria:

- Personal CRC history

- Additional exclusion for Phase III: Patients seen at any clinic participating in Phase
II
We found this trial at
2
sites
Richmond, Virginia 23298
Phone: 804-827-6750
?
mi
from
Richmond, VA
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19122
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials